- Home
- VRE vs CLDX Comparison
VRE vs CLDX Comparison
Compare VRE & CLDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRE
- CLDX
- Stock Information
- Founded
- VRE 1949
- CLDX N/A
- Country
- VRE United States
- CLDX United States
- Employees
- VRE N/A
- CLDX N/A
- Industry
- VRE Real Estate Investment Trusts
- CLDX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- VRE Real Estate
- CLDX Health Care
- Exchange
- VRE Nasdaq
- CLDX Nasdaq
- Market Cap
- VRE 1.4B
- CLDX 1.3B
- IPO Year
- VRE 1994
- CLDX 2008
- Fundamental
- Price
- VRE $14.33
- CLDX $24.37
- Analyst Decision
- VRE Buy
- CLDX Strong Buy
- Analyst Count
- VRE 5
- CLDX 8
- Target Price
- VRE $19.20
- CLDX $51.86
- AVG Volume (30 Days)
- VRE 467.2K
- CLDX 1.1M
- Earning Date
- VRE 07-23-2025
- CLDX 08-07-2025
- Dividend Yield
- VRE 2.28%
- CLDX N/A
- EPS Growth
- VRE N/A
- CLDX N/A
- EPS
- VRE N/A
- CLDX N/A
- Revenue
- VRE $285,675,000.00
- CLDX $5,790,000.00
- Revenue This Year
- VRE $4.75
- CLDX N/A
- Revenue Next Year
- VRE $3.57
- CLDX N/A
- P/E Ratio
- VRE N/A
- CLDX N/A
- Revenue Growth
- VRE 5.04
- CLDX N/A
- 52 Week Low
- VRE $13.69
- CLDX $14.40
- 52 Week High
- VRE $18.85
- CLDX $47.00
- Technical
- Relative Strength Index (RSI)
- VRE 46.99
- CLDX 59.57
- Support Level
- VRE $13.99
- CLDX $24.14
- Resistance Level
- VRE $14.25
- CLDX $25.65
- Average True Range (ATR)
- VRE 0.29
- CLDX 1.33
- MACD
- VRE 0.03
- CLDX 0.30
- Stochastic Oscillator
- VRE 68.75
- CLDX 79.90
About VRE Veris Residential Inc.
Veris Residential Inc is a fully-integrated, self-administered and self-managed real estate investment trust (REIT). The company owns and operates a real estate portfolio comprised predominantly of multifamily rental properties located mainly in the Northeast and Class A office properties. The company performs substantially all real estate management, leasing, acquisition and development on an in-house basis. The properties are in three states in the Northeast, plus the District of Columbia. The company operates in two industry segments multifamily real estate & services and commercial & other real estate. The majority of revenue is from Multifamily real estate services.
About CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care.